ANVISA: MD studies no more required [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2022-07-13 19:03 (506 d 08:34 ago) – Posting: # 23144
Views: 2,164

Hi Shuanghe,

❝ I remember that you had given some talks about BE to ANVISA staff before.

Twice – the last one dealing with the necessity of multiple dose studies.
Haha, now I can write it esp. for you: See this article. If you are short in time, go straight to its Postscript.
Even shorter executive summary (for the guy in the Armani suit): Multiple dose studies are no more required for the ANVISA.
In April 2021 a revision of the guideline was promised for the next summer. If there is one, I failed to find it at the ANVISA’s website, as usual.*

❝ Maybe next time you can suggest why they should not request schedule time point :lol3:

Sure. :-D

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,638 registered users;
29 visitors (0 registered, 29 guests [including 3 identified bots]).
Forum time: 02:38 CET (Europe/Vienna)

Inspiration is constantly in the air.
It’s up to us to develop the sensitivity
to pick up on it.    Herbie Hancock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz